Stimulation of mast cells via FcɛR1 and TLR2: The type of ligand determines the outcome
Authors:
- Fillip PortFPFillip Port
- Gordon GrochowyGGGordon Grochowy
- Christoph KalisCKChristoph Kalis
- Wolfgang BesslerWBWolfgang Bessler
- Chris GalanosCGChris Galanos
- Gerald KrystalGKGerald Krystal
- Marina FreudenbergMFMarina Freudenberg
- Michael HuberMHMichael Huber
- 1 March 2007
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 44 (8) , 2087-2094
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- R‐form LPS, the master key to the activation ofTLR4/MD‐2‐positive cellsEuropean Journal of Immunology, 2006
- Lipopolysaccharide-Mimetic Activities of a Toll-Like Receptor 2-Stimulatory Substance(s) in Enterobacterial Lipopolysaccharide PreparationsInfection and Immunity, 2003
- Overview of the Alliance for Cellular SignalingNature, 2002
- BCR mutants deficient in ligand-independent and more sensitive for ligand-dependent signalingEuropean Journal of Immunology, 2002
- MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?Innate Immunity, 2000
- Chlamydia pneumoniaeand its role in chronic obstructive pulmonary diseaseAnnals of Medicine, 1998
- B Cell Development under the Condition of Allelic InclusionImmunity, 1997
- Measurement of IgE on Rat Mast Cells: Relation to Serum IgE and Allergen‐Induced Histamine ReleaseScandinavian Journal of Immunology, 1983
- The Effect of Hapten-Specific Suppression of IgE on Antigen-Induced Histamine Release from Mouse Peritoneal Mast CellsInternational Archives of Allergy and Immunology, 1979
- Analysis of the repertoire of anti‐NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune responseEuropean Journal of Immunology, 1978